These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 19162084)

  • 1. A neurocomputational model of tonic and phasic dopamine in action selection: a comparison with cognitive deficits in Parkinson's disease.
    Guthrie M; Myers CE; Gluck MA
    Behav Brain Res; 2009 Jun; 200(1):48-59. PubMed ID: 19162084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying the Basal Ganglia network model markers for medication-induced impulsivity in Parkinson's disease patients.
    Balasubramani PP; Chakravarthy VS; Ali M; Ravindran B; Moustafa AA
    PLoS One; 2015; 10(6):e0127542. PubMed ID: 26042675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A neurocomputational model of dopamine and prefrontal-striatal interactions during multicue category learning by Parkinson patients.
    Moustafa AA; Gluck MA
    J Cogn Neurosci; 2011 Jan; 23(1):151-67. PubMed ID: 20044893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine modulates striatal response to reward and punishment in patients with Parkinson's disease: a pharmacological challenge fMRI study.
    Argyelan M; Herzallah M; Sako W; DeLucia I; Sarpal D; Vo A; Fitzpatrick T; Moustafa AA; Eidelberg D; Gluck M
    Neuroreport; 2018 May; 29(7):532-540. PubMed ID: 29432300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain dopaminergic modulation associated with executive function in Parkinson's disease.
    Farid K; Sibon I; Guehl D; Cuny E; Burbaud P; Allard M
    Mov Disord; 2009 Oct; 24(13):1962-9. PubMed ID: 19672989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neural dynamics of short and medium-term motor control effects of levodopa therapy in Parkinson's disease.
    Contreras-Vidal JL; Poluha P; Teulings HL; Stelmach GE
    Artif Intell Med; 1998 May; 13(1-2):57-79. PubMed ID: 9654379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levodopa medication improves incidental sequence learning in Parkinson's disease.
    Beigi M; Wilkinson L; Gobet F; Parton A; Jahanshahi M
    Neuropsychologia; 2016 Dec; 93(Pt A):53-60. PubMed ID: 27686948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of dopamine in cognitive sequence learning: evidence from Parkinson's disease.
    Shohamy D; Myers CE; Grossman S; Sage J; Gluck MA
    Behav Brain Res; 2005 Jan; 156(2):191-9. PubMed ID: 15582105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic dopamine modulation in the basal ganglia: a neurocomputational account of cognitive deficits in medicated and nonmedicated Parkinsonism.
    Frank MJ
    J Cogn Neurosci; 2005 Jan; 17(1):51-72. PubMed ID: 15701239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of dopamine on reinforcement learning in Parkinson's disease depend on motor phenotype.
    van Nuland AJ; Helmich RC; Dirkx MF; Zach H; Toni I; Cools R; den Ouden HEM
    Brain; 2020 Dec; 143(11):3422-3434. PubMed ID: 33147621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose dependent dopaminergic modulation of reward-based learning in Parkinson's disease.
    van Wouwe NC; Ridderinkhof KR; Band GP; van den Wildenberg WP; Wylie SA
    Neuropsychologia; 2012 Apr; 50(5):583-91. PubMed ID: 22223079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ventral striatal network connectivity reflects reward learning and behavior in patients with Parkinson's disease.
    Petersen K; Van Wouwe N; Stark A; Lin YC; Kang H; Trujillo-Diaz P; Kessler R; Zald D; Donahue MJ; Claassen DO
    Hum Brain Mapp; 2018 Jan; 39(1):509-521. PubMed ID: 29086460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The default mode network integrity in patients with Parkinson's disease is levodopa equivalent dose-dependent.
    Krajcovicova L; Mikl M; Marecek R; Rektorova I
    J Neural Transm (Vienna); 2012 Apr; 119(4):443-54. PubMed ID: 22002597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational cognitive models of prefrontal-striatal-hippocampal interactions in Parkinson's disease and schizophrenia.
    Moustafa AA; Gluck MA
    Neural Netw; 2011 Aug; 24(6):575-91. PubMed ID: 21411277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine is associated with prioritization of reward-associated memories in Parkinson's disease.
    Sharp ME; Duncan K; Foerde K; Shohamy D
    Brain; 2020 Aug; 143(8):2519-2531. PubMed ID: 32844197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phasic Dopamine Changes and Hebbian Mechanisms during Probabilistic Reversal Learning in Striatal Circuits: A Computational Study.
    Schirru M; Véronneau-Veilleux F; Nekka F; Ursino M
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease.
    Cools R
    Neurosci Biobehav Rev; 2006; 30(1):1-23. PubMed ID: 15935475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paradoxical effect of dopamine medication on cognition in Parkinson's disease: relationship to side of motor onset.
    Hanna-Pladdy B; Pahwa R; Lyons KE
    J Int Neuropsychol Soc; 2015 Apr; 21(4):259-70. PubMed ID: 25923830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. l-DOPA changes ventral striatum recruitment during motor sequence learning in Parkinson's disease.
    Kwak Y; Müller ML; Bohnen NI; Dayalu P; Seidler RD
    Behav Brain Res; 2012 Apr; 230(1):116-24. PubMed ID: 22343069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of the prefrontal cortex revealed by PET.
    Cools R; Stefanova E; Barker RA; Robbins TW; Owen AM
    Brain; 2002 Mar; 125(Pt 3):584-94. PubMed ID: 11872615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.